LAVA Therapeutics N.V. (LVTX)
NASDAQ: LVTX · Real-Time Price · USD
1.330
-0.020 (-1.48%)
Mar 13, 2025, 4:00 PM EST - Market closed
LAVA Therapeutics Employees
LAVA Therapeutics had 37 employees as of December 31, 2023. The number of employees decreased by 32 or -46.38% compared to the previous year.
Employees
37
Change (1Y)
-32
Growth (1Y)
-46.38%
Revenue / Employee
$198,514
Profits / Employee
-$747,081
Market Cap
34.98M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 37 | -32 | -46.38% |
Dec 31, 2022 | 69 | 11 | 18.97% |
Dec 31, 2021 | 58 | 27 | 87.10% |
Dec 31, 2020 | 31 | - | - |
LVTX News
- 13 days ago - Analyst Downgrades LAVA Therapeutics, Sees Pipeline Overhang - Benzinga
- 2 months ago - LAVA Doses First Patient in Phase 1 LAVA-1266 Study in Hematological Cancers - GlobeNewsWire
- 3 months ago - LAVA Reports Third Quarter 2024 Financial Results and Announces Pipeline Reprioritization and Cash Runway Extension into 2027 - GlobeNewsWire
- 6 months ago - LAVA Therapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire
- 7 months ago - LAVA Reports Second Quarter 2024 Financial Results and Business Update - GlobeNewsWire
- 9 months ago - LAVA Therapeutics to Participate in the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference - GlobeNewsWire
- 9 months ago - LAVA Announces Annual Meeting of Shareholders - GlobeNewsWire
- 10 months ago - LAVA Therapeutics to Participate in the Jefferies Global Healthcare Conference - GlobeNewsWire